SP-MHCI-0342-3

Murine coronavirus (strain 4) Spike 510-518, CSLWNGPHL

US$507.00

In stock

Description

About Murine coronavirus (strain 4) Spike 510-518, CSLWNGPHL

The Murine coronavirus (strain 4) Spike glycoprotein Peptide (IEDB: 7032) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Spike glycoprotein Peptide, H-CSLWNGPHL-OH (Uniprot: P22432 aa: 510-518) from JPT is produced under strict quality control and quality management.

Murine coronavirus (strain 4) Spike 510-518, CSLWNGPHL - Specifications

  • Peptide sequence: H-CSLWNGPHL-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Encephalitis
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Murine coronavirus (strain 4) Spike 510-518, CSLWNGPHL

References:
Read References with JPT’s Antigen Peptides
Murine coronavirus (strain 4) Spike 510-518, CSLWNGPHL has been described in:
Very diverse CD8 T cell clonotypic responses after virus infections., J Immunol, 2004 (PMID: 14978121)
Protection against CTL escape and clinical disease in a murine model of virus persistence., J Immunol, 2003 (PMID: 12902505)
Immunodominant cytomegalovirus-specific CD8+ T-cell responses in sub-Saharan African populations., PLoS One, 2017 (PMID: 29232408)

Documentation

Documentation for Murine coronavirus (strain 4) Spike 510-518, CSLWNGPHL

Properties

Properties of Murine coronavirus (strain 4) Spike 510-518, CSLWNGPHL

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Encephalitis
Layout: Freeze-dried in glass vial
Organism: Murine coronavirus
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Murine coronavirus (strain 4) Spike 510-518, CSLWNGPHL

Information Values
Sequence: H-CSLWNGPHL-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote